Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 3Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Vascular Diseases 2Heart Diseases 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms, Second Primary 1Metabolic Diseases 1Heart Failure 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Cancer Metastatic 1Cardiovascular Diseases 1Cardiotoxicity 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasms 1Advanced Ovarian Cancer 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Antineoplastic Agents × Clear all
NCT06409481 2024-05-10

PARCA

The First Affiliated Hospital of Xinxiang Medical College

Unknown
800,000 enrolled

Cardiovascular Diseases, Heart Diseases, Neoplasms, Vascular Diseases

NCT04696250 2021-01-06

AVATAR

University Hospital, Caen

Unknown
5,000,000 enrolled
Tumor-Agnostic

Neoplasms

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown
200 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡